Artificial Intelligence in Healthcare Diagnosis Market Forecast and Growth 2030

Artificial Intelligence in Healthcare Diagnosis Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Diagnostic Tool (Medical Imaging Tool, Automated Detection System, and Others), Application (Eye Care, Oncology, Radiology, Cardiovascular, and Others), End User (Hospital and Clinic, Diagnostic Laboratory, and Home Care), and Service (Tele-Consultation, Tele Monitoring, Others)and Geography

  • Report Code : TIPRE00011852
  • Category : Healthcare IT
  • No. of Pages : 150
Buy Now

Artificial Intelligence in Healthcare Diagnosis Market Size | 2031

Buy Now

The artificial intelligence in healthcare diagnosis market was estimated to be US$ 7.43 billion in 2021 and US$ xx billion in 2023. It is expected to reach US$ 193.09 billion by 2031 and record a CAGR of 38.5% until 2031. AI-powered Imaging solutions, remote monitoring and telemedicine, predictive analytics and early detection will likely remain key artificial intelligence in healthcare diagnosis market trends.

Artificial Intelligence in Healthcare Diagnosis Market Analysis

Key factors driving the market such as growing adoption of Artificial Intelligence (AI) in disease diagnosis and identification and increasing investment in AI healthcare start-ups are expected to drive the market's growth. Integration of AI in diagnostic procedures is transforming the diagnostic and patient care industry.  For instance, in October 2023, Philips collaborated with Spain based Quilbim to provide AI imaging and reporting tools to support magnetic resonance (MR) prostate examinations.

However, lack of skilled AI workforce and ambiguous regulatory guidelines for medical software hinder market growth.

Artificial Intelligence in Healthcare Diagnosis Market Overview

Global artificial intelligence in healthcare diagnosis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The market growth in this region is expected owing to factors such as the growing need to reduce healthcare costs and the importance of big data in healthcare, which are some factors driving growth. In addition, increasing applicability of AI-based tools in medical care and rise in capital investments. In addition, the rising adoption of Artificial Intelligence (AI) in disease diagnosis and identification and increasing investment in AI healthcare start-ups are leading to market growth during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Artificial Intelligence in Healthcare Diagnosis Market: Strategic Insights

Artificial Intelligence in Healthcare Diagnosis Market

  • CAGR (2023 - 2031)
    38.5%
  • Market Size 2021
    US$ 7.43 Billion
  • Market Size 2031
    US$ 193.09 Billion

Market Dynamics

GROWTH DRIVERS
  • Increasing Investment in AI Healthcare Start-ups to Favor the Market
FUTURE TRENDS
  • AI in Epidemic Outbreak Prediction and Response
OPPORTUNITIES
  • Increasing Potential in Emerging Economies

Key Players

  • Microsoft,
  • Koninklijke Philips N.V.,
  • Intel Corporation,
  • General Electric Company,
  • Alphabet Inc.,
  • NVIDIA CORPORATION,
  • Nuance Communications, Inc.,
  • Siemens Healthineers AG,
  • Arterys Inc.,
  • Johnson and Johnson Services, Inc.,

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Diagnostic Tool
  • Medical Imaging Tool
  • Automated Detection System
  • Others
Application
  • Eye Care
  • Oncology
  • Radiology
  • Cardiovascular
  • Others
End User
  • Hospital and Clinic
  • Diagnostic Laboratory
  • Home Care
Service
  • Tele-Consultation
  • Tele Monitoring
  • Others
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Artificial Intelligence in Healthcare Diagnosis Market Drivers and Opportunities

Increasing Number of Product Launches to Favor the Market.

AI in healthcare is one of the most significant technological advancements so far. Healthcare startups are developing AI-driven diagnostic and therapeutic solutions, which are the major factors responsible for the market's growth in the study period. In May 2023, Lumibird Medical launched the C.DIAG, a dry eye diagnostic aid platform that utilizes artificial intelligence (AI) algorithms. Similarly, in April 2024, General Electric Company launched Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL.

Increasing Potential in Emerging Economies – An Opportunity in Artificial Intelligence in Healthcare Diagnosis Market

AI can also improve constraints from poor infrastructure in emerging markets by providing alternatives and cost-effective solutions to deliver services to those who need them most, including remote communities. Using the widespread coverage of mobile networks, AI is used in telemedicine for early disease diagnosis, saving the cost of maintaining an extensive network of community health workers. Cancer screening and treatment is where AI provides remarkable reach for targeted large-scale interventions. India witnesses a prevalence of more than 1 million new cases of cancer annually. This number is likely to increase, owing to the increasing geriatric Indian population and lifestyle changes. For a yearly incidence of more than 1 million new cancer cases every year, India has barely 2,000 experienced pathologists in oncology and less than 500 pathologists who could be considered an expert oncopathologist.

Thus, integrating AI in diagnostic solutions can build more resilient and sustainable healthcare systems in emerging nations.

Artificial Intelligence in Healthcare Diagnosis Market Report Segmentation Analysis

Key segments that contributed to the artificial intelligence in healthcare diagnosis market analysis derivation are services and applications.

  • Based on diagnostic tools, artificial intelligence in the healthcare diagnosis market is divided into medical imaging tool, automated detection systems, and others. The medical imaging tool segment held a larger market share in 2023. However, the automated detection system and is anticipated to register the highest CAGR in the market during the forecast period.
  • The market is segmented by application into eye care, oncology, radiology, cardiovascular, and others. The oncology segment held the largest share of the market in 2023. However, radiology segment is anticipated to witness the fastest growth rate in the market during the forecast period.
  • By end-user, the artificial intelligence in the healthcare diagnosis market has been segmented into hospital and clinic, diagnostic laboratories, and home care. The hospital and clinic segment held the largest share of the market, whereas the diagnostic laboratory segment is estimated to witness the fastest growth rate in the market during the forecast period.
  • Based on service, the artificial intelligence in healthcare diagnosis market has been segmented tele-consultation, telemonitoring, and other service. The tele-consultation segment held the largest share of the market, whereas the tele-monitoring segment is estimated to register the highest CAGR in the market during the forecast period.

Artificial Intelligence in Healthcare Diagnosis Market Share Analysis by Geography

The geographic scope of the artificial intelligence in healthcare diagnosis market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America is the largest market for the artificial intelligence in healthcare diagnosis market, with the US holding the largest market share, followed by Canada. The growth of the market in the US is driven by factors such as, the need to reduce healthcare costs, growing importance of big data in healthcare and rising capital investment are contributing in the demand for AI in healthcare diagnosis. Similarly, in Canada, increasing government initiatives to implement AI based technologies across the country are contributing to market growth.

The Asia Pacific is the fastest-growing market for artificial intelligence in healthcare diagnosis in a global scenario. The region is analyzed based on China, India, Japan, Australia, South Korea, and the rest of the Asia Pacific. The region is expected to have several growth opportunities for the market growth owing to the lack of healthcare professionals, increasing prevalence of chronic diseases, increasing investment in startups and improving healthcare infrastructure in the region.

Artificial Intelligence in Healthcare Diagnosis Market Report Scope

Report Attribute Details
Market size in 2021 US$ 7.43 Billion
Market Size by 2031 US$ 193.09 Billion
Global CAGR (2023 - 2031) 38.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Diagnostic Tool
  • Medical Imaging Tool
  • Automated Detection System
  • Others
By Application
  • Eye Care
  • Oncology
  • Radiology
  • Cardiovascular
  • Others
By End User
  • Hospital and Clinic
  • Diagnostic Laboratory
  • Home Care
By Service
  • Tele-Consultation
  • Tele Monitoring
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Microsoft,
  • Koninklijke Philips N.V.,
  • Intel Corporation,
  • General Electric Company,
  • Alphabet Inc.,
  • NVIDIA CORPORATION,
  • Nuance Communications, Inc.,
  • Siemens Healthineers AG,
  • Arterys Inc.,
  • Johnson and Johnson Services, Inc.,
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Artificial Intelligence in Healthcare Diagnosis Market News and Recent Developments

    The artificial intelligence in healthcare diagnosis market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for artificial intelligence in healthcare diagnosis and strategies:

    • In May 2023, Digital Diagnostics launched its LumineticsCore Al diagnostic system in the southeast region of the US. LumineticsCore is a De Novo FDA-cleared autonomous AI diagnostic system (Source: Company Press Release)
    • In December 2021, F. Hoffmann-La Roche Ltd launched its artificial intelligence (AI) based digital pathology algorithms to aid pathologists in evaluating breast cancer markers, Ki-67, ER and PR. (Source: Company Press Release)

    Artificial Intelligence in Healthcare Diagnosis Market Report Coverage and Deliverables

    The “Artificial Intelligence in Healthcare Diagnosis Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Diagnostic Tool ; Application ; End User ; Service ; and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Trends and growth analysis reports related to Healthcare IT : READ MORE..